Lazard Asset Management
ASTH icon

Lazard Asset Management’s Astrana Health ASTH Stock Holding History

Lazard Asset Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-74,285
Closed -$1.84M – 2106
2025
Q4 		$1.84M Buy
+74,285
New +$1.97M ﹤0.01% 906
2023
Q2 		– Sell
-267
Closed -$9K – 2572
2023
Q1 		$9K Sell
267
-3,173
-92% -$111K ﹤0.01% 2137
2022
Q4 		$101K Hold
3,440
– – ﹤0.01% 1533
2022
Q3 		$134K Hold
3,440
– – ﹤0.01% 1361
2022
Q2 		$132K Buy
3,440
+2,064
+150% +$78.5K ﹤0.01% 1402
2022
Q1 		$66K Buy
+1,376
New +$71K ﹤0.01% 1608
2021
Q1 		– Sell
-3,244
Closed -$59K – 2056
2020
Q4 		$59K Buy
3,244
+2,802
+634% +$50.4K ﹤0.01% 1333
2020
Q3 		$7K Buy
+442
New +$7.63K ﹤0.01% 1523

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Lazard Asset Management's ASTH Position: Q1 2026 in Review

Lazard Asset Management sold out of Astrana Health (ASTH) in Q1 2026, closing a stake of 74,285 shares — an estimated $1.84M sold.

Lazard Asset Management first reported a position in ASTH in Q3 2020 and held it in 8 quarters. The position peaked at $1.84M in Q4 2025. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

  • Lazard Asset Management reported no remaining Astrana Health position as of Q1 2026 after selling out during the quarter.
  • Lazard Asset Management sold 74,285 Astrana Health shares in Q1 2026, an estimated $1.84M.
  • Lazard Asset Management first reported a position in Astrana Health in Q3 2020 and held it in 8 quarters.
  • Lazard Asset Management's Astrana Health position peaked at $1.84M in Q4 2025.
  • 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.